We are live on
!
Find out more
WSCM
Wellington Shields Capital Management Portfolio holdings
AUM
$788M
1-Year Est. Return
66.95%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+66.95%
3 Year Est. Return
+136.75%
5 Year Est. Return
+153.04%
10 Year Est. Return
+476.57%
AUM
$831M
AUM Growth
+$7.15M
(+0.87%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
63.48%
Holding
334
New
21
Increased
86
Reduced
62
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$6.06M |
| 2 |
Apple
AAPL
|
+$4.92M |
| 3 |
Salesforce
CRM
|
+$4.34M |
| 4 |
Primerica
PRI
|
+$3.86M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$3.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$7.39M |
| 2 |
Chevron
CVX
|
+$3.25M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$2.34M |
| 4 |
Royalty Pharma
RPRX
|
+$1.9M |
| 5 |
Carlyle Group
CG
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 49.79% |
| 2 | Technology | 11.4% |
| 3 | Healthcare | 8.32% |
| 4 | Financials | 8.07% |
| 5 | Industrials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Corteva
CTVA
$50.9B
| $123K | 0.01% |
2,045
+800
| +64% | +$48.9K |
|
252
Oracle
ORCL
$418B
| $120K | 0.01% |
1,295
| – | – |
|
253
Generac Holdings
GNRC
$12.7B
| $116K | 0.01% |
1,075
-600
| -36% | -$69.4K |
|
254
Invesco Preferred ETF
PGX
$3.76B
| $112K | 0.01% |
9,734
+28
| +0.3% | +$336 |
|
255
United Bankshares
UBSI
$6.61B
| $112K | 0.01% |
3,173
| – | – |
|
256
Aflac
AFL
$61B
| $110K | 0.01% |
1,700
| – | – |
|
257
Southern Company
SO
$106B
| $108K | 0.01% |
1,547
+2
| +0.1% | +$135 |
|
258
Citigroup
C
$228B
| $106K | 0.01% |
2,266
-4,653
| -67% | -$228K |
|
259
KKR & Co
KKR
$99.7B
| $105K | 0.01% |
2,000
| – | – |
|
260
Zebra Technologies
ZBRA
$18.1B
| $105K | 0.01% |
+330
| New | +$99.7K |
|
261
Coca-Cola Femsa
KOF
$22.8B
| $101K | 0.01% |
1,250
-250
| -17% | -$18.4K |
|
262
CDW
CDW
$17B
| $97.4K | 0.01% |
+500
| New | +$98.2K |
|
263
AES
AES
$10.5B
| $96.3K | 0.01% |
4,000
| – | – |
|
264
RPM International
RPM
$14.9B
| $96K | 0.01% |
1,100
| – | – |
|
265
Texas Instruments
TXN
$257B
| $94.9K | 0.01% |
510
| – | – |
|
266
Medtronic
MDT
$115B
| $94.3K | 0.01% |
+1,170
| New | +$95.4K |
|
267
Baxter International
BAX
$14.4B
| $93.3K | 0.01% |
2,300
| – | – |
|
268
Fidelity National Information Services
FIS
$22.2B
| $90.9K | 0.01% |
1,674
+4
| +0.2% | +$260 |
|
269
iShares MSCI USA Momentum Factor ETF
MTUM
$25.4B
| $87.6K | 0.01% |
630
| – | – |
|
270
Comcast
CMCSA
$90.6B
| $87.2K | 0.01% |
2,300
| – | – |
|
271
General Mills
GIS
$20.1B
| $85.5K | 0.01% |
1,000
| – | – |
|
272
DuPont de Nemours
DD
$19.5B
| $83.2K | 0.01% |
923
| – | – |
|
273
Gabelli Equity Trust
GAB
$1.79B
| $79.5K | 0.01% |
13,857
| – | – |
|
274
TJX Companies
TJX
$173B
| $74.8K | 0.01% |
955
| – | – |
|
275
Marriott International
MAR
$90.9B
| $74.7K | 0.01% |
450
| – | – |
|
Similar funds
VH
MTWSIF
AT
AVLSA
GCM
AWG
NEAM
M
Wellington Shields Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Wellington Shields Capital Management held 334 positions worth $831M, up 0.87% from $824M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Wellington Shields Capital Management's Q1 2023 filing shows 21 new, 86 increased, 62 reduced and 14 closed positions. Its largest new stake was Ares Capital: 130,655 shares worth $2.39M. The largest sale was Johnson & Johnson, an estimated $7.39M.
By sector, the portfolio is most concentrated in Consumer Staples at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
- Wellington Shields Capital Management's largest Q1 2023 buy was Ares Capital: 130,655 shares worth $2.39M.
- Wellington Shields Capital Management added most to Mastercard in Q1 2023, an estimated $6.06M increase.
- Wellington Shields Capital Management's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $7.39M.
- Wellington Shields Capital Management fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $2.34M.
- Wellington Shields Capital Management's ten largest holdings make up 63% of its $831M portfolio in Q1 2023.
- Wellington Shields Capital Management opened 21 new positions and closed 14 in Q1 2023.
- Wellington Shields Capital Management's portfolio value rose 0.87% quarter-over-quarter to $831M.
Based on Wellington Shields Capital Management's 13F filing for Q1 2023, filed 11 May 2023.